JMPWA
SGYP

JP Morgan Private Wealth Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,000
Closed -$2K – 1552
2018
Q4 		$2K Hold
20,000
– – ﹤0.01% 1443
2018
Q3 		$34K Hold
20,000
– – ﹤0.01% 1552
2018
Q2 		$35K Hold
20,000
– – ﹤0.01% 1447
2018
Q1 		$37K Hold
20,000
– – ﹤0.01% 1263
2017
Q4 		$45K Hold
20,000
– – ﹤0.01% 1269
2017
Q3 		$58K Buy
+20,000
New +$68.2K ﹤0.01% 1213

Other funds holding SGYP

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

JP Morgan Private Wealth Advisors's SGYP Position: Q1 2019 in Review

JP Morgan Private Wealth Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 20,000 shares — an estimated $2K sold.

JP Morgan Private Wealth Advisors first reported a position in SGYP in Q3 2017 and held it in 6 quarters. The position peaked at $58K in Q3 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • JP Morgan Private Wealth Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 20,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
  • JP Morgan Private Wealth Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2017 and held it in 6 quarters.
  • JP Morgan Private Wealth Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $58K in Q3 2017.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2019, filed 30 Apr 2019.